Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study

Launched by SPECTRUM HEALTH HOSPITALS · Nov 23, 2022

Keywords

ClinConnect Summary

Patients eligible for VAD are being sampled before surgery for plasma as well as peripheral blood cells. After surgery patients are being sampled again at 24 h and 7 days. Inflammatory response is being monitored on gene expression as well as cell level and on cytokine level in relation to the outcome.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subject is ≥ 18 years of age
• • 2. Subject is treated with a VAD at the Butterworth Campus, Spectrum Health.
• Exclusion Criteria:
• • 1. Subject is less than 18 years of age.
• • 2. Known prisoners of the state.
• • 3. Subject is pregnant.
• • 4. Non- English speaking patients will be excluded from the blood sub-study

Trial Officials